12 executive moves from June

A list of top executive happenings in June.

  1. Promise Healthcare of Wichita Falls has announced Louis Bradley Jr. as chief executive officer of the company's Dallas market.
  2. athenahealth Inc. has announced the appointment of Tom Szkutak, former Amazon.com CFO, to its board of directors.
  3. Sunspire Health has announced that Keith Arnold has been appointed as chief marketing and outreach officer.
  4. Andrew W. Gurman, MD, an orthopedic hand surgeon from Hollidaysburg, Pa., has been sworn in as the 171th president of the American Medical Association (AMA).
  5. Rosanna Morris, RN, has been appointed president of Beaumont Hospital in Royal Oak, Mich.
  6. Geisinger Health System in Danville, Pa., has announced the new executive vice president and chief strategy officer is Dominic Moffa.
  7. Donald D. Trexler has been named CEO of Acadia General Hospital in Crowley, La., part of Lafayette (La.) General Health.
  8. Commonwealth Health Berwick (p Hospital Center has appointed Doreen Kolojejchick as chief nursing officer and Mark McHugh as assistant chief executive officer.
  9. Darcy Burthay, MSN, RN, has been named President and CEO of Providence Health System in Washington, D.C.
  10. Community Hospital and Community Care Network Inc. in Munster, Ind., have named Luis Molina as chief executive officer.
  11. St. Luke's Hospital in Columbus, S.C., has named James B. Bross its new chief executive officer.
  12. Frank Ghinassi, PhD, has been named CEO of Trenton, N.J.-based Rutgers University Behavioral Health Care.
""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.